We pride ourselves in running a patient-focused innovation program dedicated to advanced wound care and bleeding control. Our team is always exploring new opportunities and technologies to develop cutting-edge products and design new innovative solutions to improve patient care.

Are you interested in licensing Tricol Biomedical technology? Please contact us using the form on this page. Depending on the technology of interest, we can accommodate a range of licensing alternatives, including exclusive, non-exclusive, field of use and other limited licenses.

Visit our Education Center for studies, abstract, training materials, and more!

 

Tricol Biomedical HemCon® Bandage, HemCon® Gauze, HemCon® Dental Family & m.doc® Product Family Patents:

Patents

HemCon® Bandage Family
(HemCon® Bandage PRO, HemCon Patch® PRO, ChitoDot®, HemCon® Strip PRO, ChitoFlex® PRO)
CountryGranted Patent
United States7482503
United States7820872
United States8269058
United States8313474
United States8668924
Netherlands1401352
Korea953465
Korea953466
Korea10-1105081
Korea10-1148248
Japan4332030
Japan4812630
Japan4854084
Israel159339
Israel184044
United KingdomEP1401352
United KingdomEP1704225
FranceEP1401352
FranceEP1704225
European Patent Office1401352
European Patent Office1704225
Germany1401352
Germany1704225
Canada2450668
Australia2002312493
HemCon® Gauze Family
(ChitoGauze® PRO, ChitoGauze®XR PRO, GuardaCare® PRO)
Country CodeGranted Patent
US9,205,170
KR10-1548766
JP5726068
CN102076364
HemCon® Dental Family
(HemCon® Dental Dressing PRO)
Country CodeGranted Patent
US7482503
US7820872
US7,897,832
US8269058
US8313474
US8668924
US9,004,918
NL1401352
KR953465
KR953466
KR10-1105081
KR10-1148248
KR10-1406566
JP4332030
JP4812630
JP4854084
JP5,474,351
IL159339
IL184044
GB1401352
GB1704225
FR1401352
FR1704225
EP1401352
EP1704225
DE1401352
DE1704225
CNZL200680047919.X
CA2450668
AU2002312493
m.doc® Family
(m.doc® Spray, Plasters, Nose Plugs, and Gel)
Country CodeGranted PatentNoteInstructions
US6372196Applicable to m.doc spray only
US6372718
US8445671
US8865680Applicable to m.doc gel only
JP4362620
JP5331994
IT956305
IE82995
IE1919959
GB1919959
GB2335921
GB2575907Applicable to m.doc gel only
FR956305
FR1919959
FR2575907Applicable to m.doc gel only
EP2575907Applicable to m.doc gel only
EP956305
DE1919959
DE602011018244.7Applicable to m.doc gel only
DE69802666.7-08
CZ1919959
CA2279649

Tricol Biomedical Patent Families for Bioabsorbable, Biocompatible Chitosan; Percutaneous Vascular Injury Treatment Systems and Methods; Carbonic Acid Chitosan; Bioadhesive Chitosan Surgical Gel; and Superfine Chitosan Fiber can be found below:

HemCon® Advanced Chitosan Uses
AreaPatents
Biocompatible and Bioabsorbable Derivatized Chitosan Compositionse.g., U.S. Patent Nos. 9,925,310, 9,547,011, and patents pending.
Percutaneous vascular injury treatment systems and methodse.g., PCT/US2016/012732, published as WO/2016/112342, and patents pending.
Bioadhesive chitosan gel for controlling bleeding and for promoting healing with scar reduction without obscuring or interfering with access to a surgical fielde.g., PCT/US2016/026939, published as WO/2016/164903, and patents pending.
Chitosan Superfine Fiber Systemse.g., PCT/US17/17685, published as WO 2017/139775, and patents pending.
  • This field is for validation purposes and should be left unchanged.